Acupuncture as effective as drugs for pain relief: study

Image
Press Trust of India Melbourne
Last Updated : Jun 19 2017 | 2:22 PM IST
Acupuncture may be a safe and effective alternative to painkillers in providing long-term relief for patients with severe pain, a study suggests.
Researchers from RMIT University in Australia conducted a trial in the emergency departments of four hospitals involving about 528 patients with acute low back pain, migraine or ankle sprains.
Acupuncture is a form of alternative medicine in which thin needles are inserted into the body. It is a key component of traditional Chinese medicine.
Patients who identified their level of pain as at least four on a 10-point scale randomly received one of three types of treatment - acupuncture alone, acupuncture plus pharmacotherapy (treatment using drugs) or pharmacotherapy alone.
Researchers noted that one hour after treatment, less than 40 per cent of patients across all three groups felt any significant pain reduction, while more than 80 per cent continued to have a pain rating of at least four.
However, 48 hours later, the vast majority found their treatment acceptable, with 82.8 per cent of acupuncture-only patients saying they would probably or definitely repeat their treatment, compared with 80.8 per cent in the combined group, and 78.2 per cent in the pharmacotherapy-only group, researchers said.
"Our study has shown acupuncture is a viable alternative, and would be especially beneficial for patients who are unable to take standard pain-relieving drugs because of other medical conditions," said Marc Cohen, professor at RMIT University.
While acupuncture is widely used by practitioners in community settings for treating pain, it is rarely used in hospital emergency departments, researchers said.
"We need to determine the conditions that are most responsive to acupuncture, the feasibility of including the treatment in emergency settings, and the training needed for doctors or allied health personnel," Cohen said.
The study was published in the Medical Journal of Australia.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 19 2017 | 2:22 PM IST

Next Story